Loading insider details...
Beta
Latest Form 4 (Feb 20, 2025): Grant/Award of 1,612,032 ADAP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 20, 2025 | Adaptimmune Therapeutics PLC (ADAP) | Grant/Award | 1,612,032 | n/a |
| Jan 18, 2025 | Adaptimmune Therapeutics PLC (ADAP) | Sale | 5,584 | $3.2K |
| Jan 15, 2025 | Adaptimmune Therapeutics PLC (ADAP) | Sale | 4,268 | $2.5K |
| Jan 17, 2024 | Adaptimmune Therapeutics PLC (ADAP) | Sale | 2,287 | $1.8K |
| Jan 17, 2024 | Adaptimmune Therapeutics PLC (ADAP) | Grant/Award | 2,544,432 | n/a |
| Jan 12, 2024 | Adaptimmune Therapeutics PLC (ADAP) | Sale | 4,009 | $3.4K |
| Jan 18, 2023 | Adaptimmune Therapeutics PLC (ADAP) | Sale | 2,159 | $4.0K |
| Jan 18, 2023 | Adaptimmune Therapeutics PLC (ADAP) | Grant/Award | 1,407,072 | n/a |
| Jan 13, 2023 | Adaptimmune Therapeutics PLC (ADAP) | Sale | 3,843 | $6.7K |
| Jan 5, 2023 | Adaptimmune Therapeutics PLC (ADAP) | Sale | 876 | $1.5K |